December 1, 2020

EU regulator to decide on Pfizer/BioNTech Covid-19 jab first

Frankfurt am Main (AFP) – Europe’s medicines regulator said Tuesday it would decide by December 29 whether to grant emergency approval to a Covid-19 vaccine developed by Germany’s BioNTech and its US partner Pfizer, ahead of a rival treatment from Moderna.The European Medicines Agency (EMA) confirmed that it had received formal applications from both vaccine makers seeking the green light for their experimental jabs.”If the data submitted are robust enough to conclude on the quality, safety and effectiveness of the vaccine,” the Amsterdam-based agency said it could conclude its assessment of t…


Leave a Reply

Your email address will not be published. Required fields are marked *